Management of Retinitis Pigmentosa Via Combination of Wharton's Jelly-derived Mesenchymal Stem Cells and Magnovision

Clinical trial NCT05800301 · COMPLETED

Trial details

NCT number: NCT05800301
Sponsor: Ankara Universitesi Teknokent
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Retinitis Pigmentosa

Start date: 2019-01-01
Primary completion: 2021-12-31
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.